Skip to main content

VCU spinout BioCircuit Technologies raises $9M to bring Nerve Tape to market

The company received Section 510(k) clearance from the Food and Drug Administration for its product.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.